Summit Therapeutics Receives FDA Fast Track Designation for Novel Antibiotic SMT19969 in the Treatment of C. difficile Infection

World News: . []

OXFORD United LINK  July 8 2015 GLOBE NEWSWIRE -- Summit Therapeutics plc LINK  NASDAQSMMT the drug discovery and development company LINK  therapies for Duchenne LINK  dystrophy and infection CDI LINK  that the US F ood and...

More news and information about Summit Therapeutics plc

Published By:

Globe Newswire: 12:00 GMT Wednesday 8th July 2015

Published: .

Search for other references to "summit" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us